Detalhe da pesquisa
1.
Pilot Study on the Impact of Polymorphisms Linked to Multi-Kinase Inhibitor Metabolism on Lenvatinib Side Effects in Patients with Advanced Thyroid Cancer.
Int J Mol Sci
; 24(6)2023 Mar 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-36982571
2.
Thyroid Cancers: From Surgery to Current and Future Systemic Therapies through Their Molecular Identities.
Int J Mol Sci
; 22(6)2021 Mar 18.
Artigo
em Inglês
| MEDLINE | ID: mdl-33803747
3.
DELAYED 131-I FIRST TREATMENT AFTER SURGERY HAS NO IMPACT ON THE MEDIAN TERM OUTCOME OF PATIENTS WITH INTERMEDIATE RISK DIFFERENTIATED THYROID CANCER.
Endocr Pract
; 26(1): 58-71, 2020 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-31557080
4.
Role of Prophylactic Central Compartment Lymph Node Dissection on the Outcome Of Patients With Papillary Thyroid Carcinoma and Synchronous Ipsilateral Cervical Lymph Node Metastases.
Endocr Pract
; 26(8): 807-817, 2020 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-33471672
5.
New insights in the molecular signature of advanced medullary thyroid cancer: evidence of a bad outcome of cases with double RET mutations.
J Med Genet
; 53(11): 729-734, 2016 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-27468888
6.
Benchmarking vector arthropod culture: an example using the African malaria mosquito, Anopheles gambiae (Diptera: Culicidae).
Malar J
; 15(1): 262, 2016 05 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27160438
7.
Stimulating Anopheles gambiae swarms in the laboratory: application for behavioural and fitness studies.
Malar J
; 14: 271, 2015 Jul 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26169677
8.
Prognostic Factors Improving ATA Risk System and Dynamic Risk Stratification in Low- and Intermediate-Risk DTC Patients.
J Clin Endocrinol Metab
; 109(3): 722-729, 2024 Feb 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-37804529
9.
Exploring the Susceptibility to Multiple Primary Tumors in Patients with Differentiated Thyroid Cancer.
Diagnostics (Basel)
; 14(12)2024 Jun 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-38928626
10.
Radioiodine therapy in the different stages of differentiated thyroid cancer.
Best Pract Res Clin Endocrinol Metab
; 37(1): 101703, 2023 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-36151009
11.
Enlargement of a metastatic lymph node from differentiated thyroid cancer after COVID-19 vaccination.
Endocrine
; 81(3): 455-458, 2023 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-37074558
12.
Dynamic Risk Stratification Integrated with ATA Risk System for Predicting Long-Term Outcome in Papillary Thyroid Cancer.
Cancers (Basel)
; 15(18)2023 Sep 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-37760625
13.
Mathematical models as aids for design and development of experiments: the case of transgenic mosquitoes.
J Med Entomol
; 49(6): 1177-88, 2012 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-23270145
14.
Roles of Palmitoleic Acid and Its Positional Isomers, Hypogeic and Sapienic Acids, in Inflammation, Metabolic Diseases and Cancer.
Cells
; 11(14)2022 07 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-35883589
15.
Effect of Pre-Existent Sarcopenia on Oncological Outcome of Advanced Thyroid Cancer Patients Treated with Tyrosine Kinase Inhibitors.
Cancers (Basel)
; 14(19)2022 Sep 21.
Artigo
em Inglês
| MEDLINE | ID: mdl-36230491
16.
Clinical pharmacology and drug-drug interactions of lenvatinib in thyroid cancer.
Crit Rev Oncol Hematol
; 163: 103366, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-34051303
17.
[18F]-FDG-PET/CT Correlates With the Response of Radiorefractory Thyroid Cancer to Lenvatinib and Patient Survival.
J Clin Endocrinol Metab
; 106(8): 2355-2366, 2021 07 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-33901285
18.
Prevalence and Risk Factors of Developing Fistula or Organ Perforation in Patients Treated with Lenvatinib for Radioiodine-Refractory Thyroid Cancer.
Eur Thyroid J
; 10(5): 399-407, 2021 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-34540710
19.
Thyroid cancer and COVID-19: experience at one single thyroid disease referral center.
Endocrine
; 72(2): 332-339, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33638758
20.
Safety and Quality-of-Life Data from an Italian Expanded Access Program of Lenvatinib for Treatment of Thyroid Cancer.
Thyroid
; 31(2): 224-232, 2021 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-32907501